Historical record - last NADAC effective date: 1/1/2018
Product Information
ZYMAXID 0.5% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $67.3765 per ML under NDC 00023361525. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on May 18, 2010. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the gatifloxacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023361525
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
1/1/2018
Active Ingredients
GATIFLOXACINApproval Type
New Drug (NDA)
FDA Application
NDA022548FDA Approved
5/18/2010
TE Code
AT
On Market Since
5/19/2010
Pharmacological Classes
Price Statistics
The NADAC for ZYMAXID 0.5% EYE DROPS has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $67.3765 per ML |
|---|---|
| All-time high | $67.3765 (Jan 16, 2019) |
| All-time low | $42.5943 (Nov 28, 2013) |
| Median price | $58.6787 |
| Average price | $57.0924 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+58.2%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZYMAXID 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ZYMAXID 0.5% EYE DROPS, manufactured by Allergan, Inc., is $67.3765 per ML (NDC 00023361525), effective Jan 16, 2019.
How has the price of ZYMAXID 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ZYMAXID 0.5% EYE DROPS has risen 58.2%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZYMAXID 0.5% EYE DROPS?
Since Nov 28, 2013, the NADAC for ZYMAXID 0.5% EYE DROPS has ranged from a low of $42.5943 (Nov 28, 2013) to a high of $67.3765 (Jan 16, 2019), with a median of $58.6787 per ML.
Are there cheaper alternatives to ZYMAXID 0.5% EYE DROPS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GATIFLOXACIN 0.5% EYE DROPS, is $8.1826 per ML — about 88% below ZYMAXID 0.5% EYE DROPS.
Who manufactures ZYMAXID 0.5% EYE DROPS?
ZYMAXID 0.5% EYE DROPS (NDC 00023361525) is labeled by Allergan, Inc., and CMS classifies it as a brand product.